Ireland
--:--IST
Recruiting Observational

Prevalence of Abnormal Pap Smear

NCT06641531 · tracked via the Priya Life Science Egypt tracker
Phase
Observational
Started
2024-10-01
Last updated
2024-10-15

Condition(s) studied

Cervix Cancer

Investigational drug(s) / intervention(s)

Screening pap smear test

Screening pap smear test: The patient put in dorsal lithotomy position and place the feet in stirrups or on foot rests . then, the physician will insert a cusco speculum into the vagina to hold vaginal wall open . The specimens will be collected as follows; firstly, the speculum will be inserted without lubricant. Any mucous, discharge or blood will be removed with dry cotton. A wooden spatula will be used for sampling ectocervix which will be rotated 360 degrees. For sampling endocervix, A brush or a swab will be rotated only 90 degrees as the circumferential bristles will be in contact with the entire surface the moment the brush is inserted. The samples will be applied to the slides which will be encoded and immediately fixed in 95% ethanol and the samples will be transferred to pathology department to be stained by the standard Papanicolaou stain

Study summary

This study aims to evaluate prevalence of abnormal Pap smear among sexually active women of reproductive age attending sohag university hospital outpatient clinic.

Eligibility

Sex
FEMALE
Min age
21 Years
Max age
60 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Non pregnant sexually active women aged from 21 to 60 years old. * Patients who didn't have their pap smear done in last 3 years . * Patient who had previous abnormal pap smear and coming for follow up. Exclusion Criteria: * Women who were diagnosed cervical cancer that was treated. * Women who underwent total hysterectomy. * Women who are pregnant. * Patients whose pap smear was done in last 3 years with reassuring results.

Primary outcome measure(s)

  • number of abnormal pap smear among sexually active women of reproductive age attending sohag university hospital outpatient clinic. — From October 2024 to April 2025
    to evaluate prevalence of abnormal Pap smear among sexually active women of reproductive age attending sohag university hospital outpatient clinic.

Trial sites (1)

FacilityCityRegionStatus
Faculty of Medicine, Sohag University Sohag Egypt Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06641531 on ClinicalTrials.gov ↗ ← All trials in Egypt